Implications of protein flexibility for drug discovery

Molecular basis of agonism and antagonism in the oestrogen receptor

Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355 · see citing works

The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen

Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,726 · see citing works

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,922 · see citing works

Structural mechanism for statin inhibition of HMG-CoA reductase

Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644 · see citing works

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 834 · see citing works

The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity

Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., & Redinbo, M. R. (2001) · Science · doi:10.1126/science.1060762 · Cited by 760 · see citing works

Structure of acetylcholinesterase complexed with E2020 (Aricept®): implications for the design of new anti-Alzheimer drugs

Kryger, G., Silman, I., & Sussman, J. L. (1999) · Structure · doi:10.1016/s0969-2126(99)80040-9 · Cited by 755 · see citing works

Structural Mechanisms for Domain Movements in Proteins

Gerstein, M., Lesk, A. M., & Chothia, C. (1994) · Biochemistry · doi:10.1021/bi00188a001 · Cited by 741 · see citing works

Enzyme Dynamics During Catalysis

Eisenmesser, E. Z., Bosco, D. A., Akke, M., & Kern, D. (2002) · Science · doi:10.1126/science.1066176 · Cited by 732 · see citing works

A relationship between protein stability and protein function.

Shoichet, B. K., Baase, W. A., Kuroki, R., & Matthews, B. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.452 · Cited by 712 · see citing works

Loop and Subdomain Movements in the Mechanism of Escherichia coli Dihydrofolate Reductase: Crystallographic Evidence,

Sawaya, M. R., & Kraut, J. (1997) · Biochemistry · doi:10.1021/bi962337c · Cited by 676 · see citing works

Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors

Podust, L. M., Poulos, T. L., & Waterman, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061562898 · Cited by 534 · see citing works

Recent Insights into Inhibition, Structure, and Mechanism of Configuration-Retaining Glycosidases

Heightman, T. D., & Vasella, A. T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990315)38:6 · Cited by 507 · see citing works

High resolution structures of HIV-1 RT from four RT–inhibitor complexes

Ren, J., Esnouf, R. M., Garman, E. F., Somers, D. O., Ross, C., Kirby, I., Keeling, J., Darby, G. K., Jones, E. Y., Stuart, D. I., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-293 · Cited by 503 · see citing works

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

Esnouf, R. M., Ren, J., Ross, C., Jones, E. Y., STAMMERS, D. K., & Stuart, D. I. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-303 · Cited by 442 · see citing works

Structural basis of inhibitor selectivity in MAP kinases

Wang, Z., Canagarajah, B. J., Boehm, J. C., Kassisà, S., Cobb, M. H., Young, P. R., Abdel‐Meguid, S. S., Adams, J. L., & Goldsmith, E. J. (1998) · Structure · doi:10.1016/s0969-2126(98)00113-0 · Cited by 426 · see citing works

Multiple diverse ligands binding at a single protein site: A matter of pre‐existing populations

Ma, B., Shatsky, M., Wolfson, H. J., & Nussinov, R. (2002) · Protein Science · doi:10.1110/ps.21302 · Cited by 420 · see citing works

Binding of small molecules to an adaptive protein–protein interface

Arkin, M. R., Randal, M., DeLano, W. L., Hyde, J., Luong, T. N., Oslob, J. D., Raphael, D. R., Taylor, L., Wang, J., McDowell, R. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252756299 · Cited by 376 · see citing works

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A

Raves, M. L., Harel, M., Pang, Y., Silman, I., Kozikowski, A. P., & Sussman, J. L. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0197-57 · Cited by 373 · see citing works

Rational design of potent human transthyretin amyloid disease inhibitors.

Sacchettini, J. C., Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., & Kelly, J. W. (2000) · Nature Structural Biology · doi:10.1038/74082 · Cited by 373 · see citing works

Structural Mechanisms of QacR Induction and Multidrug Recognition

Schumacher, M. A., Miller, M. C., Grkovic, S., Brown, M. H., Skurray, R. A., & Brennan, R. G. (2001) · Science · doi:10.1126/science.1066020 · Cited by 369 · see citing works

Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors

Hopkins, A. L., Ren, J., Esnouf, R. M., Willcox, B. E., Jones, E. Y., Ross, C., Miyasaka, T., Walker, R. T., Tanaka, H., STAMMERS, D. K., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960056x · Cited by 349 · see citing works

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.

Smerdon, S. J., Jäger, J., Wang, J., Kohlstaedt, L. A., Chirino, A. J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3911 · Cited by 331 · see citing works

Protein flexibility and drug design: how to hit a moving target

Carlson, H. A. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00341-1 · Cited by 314 · see citing works

Three‐dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors

Harel, M., Kryger, G., Rosenberry, T. L., Mallender, W. D., Lewis, T., Fletcher, R. J., Guss, J. M., Silman, I., & Sussman, J. L. (2000) · Protein Science · doi:10.1110/ps.9.6.1063 · Cited by 299 · see citing works

Kinetic basis for selective inhibition of cyclo-oxygenases

Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/bj3390607 · Cited by 287 · see citing works

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.

Browner, M. F., Lovejoy, B., Welch, A. R., Carr, S., Luong, C., Broka, C. A., Hendricks, R. T., Campbell, J. A., Walker, K. A. M., Martin, R., et al. (1999) · Nature Structural Biology · doi:10.1038/6657 · Cited by 255 · see citing works

SURVEY AND SUMMARY: The morph server: a standardized system for analyzing and visualizing macromolecular motions in a database framework

Krebs, W. G. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.1665 · Cited by 243 · see citing works

Deciphering common failures in molecular docking of ligand-protein complexes

Verkhivker, G. M., Bouzida, D., Gehlhaar, D. K., Rejto, P. A., Arthurs, S., Colson, A. B., Freer, S. T., Larson, V., Luty, B. A., Marrone, T. J., et al. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008158231558 · Cited by 240 · see citing works

Increased protein backbone conformational entropy upon hydrophobic ligand binding.

Novotný, M. V., Stone, M. J., & Žı́dek, L. (1999) · Nature Structural Biology · doi:10.1038/70057 · Cited by 236 · see citing works

A ‘specificity’ pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil

Urzhumtsev, A., Favier, F., Mitschler, A., et al. (1997) · Structure · doi:10.1016/s0969-2126(97)00216-5 · Cited by 233 · see citing works

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

Schevitz, R. W., Bach, N. J., CARLSON, D. G., Chirgadze, N. Y., Clawson, D. K., Dillard, R. D., Draheim, S. E., Hartley, L. W., Jones, N. D., Mihelich, E. D., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0695-458 · Cited by 216 · see citing works

CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM

Poulos, T. L., & Howard, A. J. (1987) · Biochemistry · doi:10.1021/bi00399a022 · Cited by 215 · see citing works

CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE, THIOCAMPHOR, AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION

Raag, R., & Poulos, T. L. (1990) · Biochemistry · doi:10.1021/bi00224a016 · Cited by 213 · see citing works

Designing Non-Peptide Peptidomimetics in the 21st Century: Inhibitors Targeting Conformational Ensembles

Bursavich, M. G., & Rich, D. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010425b · Cited by 208 · see citing works

Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: Linkage of dynamics and structural plasticity

Morton, A., & Matthews, B. W. (1995) · Biochemistry · doi:10.1021/bi00027a007 · Cited by 200 · see citing works

Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma

Baldwin, J. J., Ponticello, G. S., Anderson, P., Christy, M. E., Murcko, M. A., Randall, W. C., Schwam, H., Sugrue, M. F., & Gautheron, P. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00132a003 · Cited by 197 · see citing works

Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 2. Crystallographic and Molecular Modeling Study of Complexes of 4-Amino-4H-pyran-6-carboxamides and Sialidase from Influenza Virus Types A and B

Taylor, N. R., Cleasby, A., Singh, O., Skarzynski, T. J., Wonacott, A. J., Smith, P. W., Sollis, S. L., Howes, P. D., Cherry, P. C., Bethell, R. C., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9703754 · Cited by 193 · see citing works

Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.

Kulmacz, R. J., & Lands, W. E. M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38909-3 · Cited by 190 · see citing works

MolMovDB: analysis and visualization of conformational change and structural flexibility

Echols, N. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg104 · Cited by 190 · see citing works

Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity

Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 177 · see citing works

Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat.

Wilson, D. K., Tarle, I., Petrash, J. M., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9847 · Cited by 163 · see citing works

The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase

Murray, C. W., Baxter, C. A., & Frenkel, A. D. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008015827877 · Cited by 161 · see citing works

Manipulation of ligand binding affinity by exploitation of conformational coupling.

Marvin, J. S., & Hellinga, H. W. (2001) · Nature Structural Biology · doi:10.1038/nsb0901-795 · Cited by 153 · see citing works

Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir

Wang, M. Z., Tai, C. Y., & Mendel, D. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3809-3816.2002 · Cited by 151 · see citing works

Mechanism of inhibition of cholinesterases by huperzine A

Ashani, Y., Peggins, J. O., & Doctor, B. P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90649-6 · Cited by 144 · see citing works

Incorporation of Magnetic Nanoparticles in New Hybrid Networks Based on Heteropolyanions and Polyacrylamide

Mayer, C. R., Cabuil, V., Lalot, T., & Thouvenot, R. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24 · Cited by 139 · see citing works

A Major Role for a Set of Non-Active Site Mutations in the Development of HIV-1 Protease Drug Resistance

Muzammil, S., Ross, P. A., & Freire, E. (2003) · Biochemistry · doi:10.1021/bi027019u · Cited by 138 · see citing works

A new allosteric site in glycogen phosphorylase b as a target for drug interactions

Oikonomakos, N. G., Skamnaki, V. T., Tsitsanou, K. E., Gavalas, N. G., & Johnson, L. N. (2000) · Structure · doi:10.1016/s0969-2126(00)00144-1 · Cited by 132 · see citing works

Human liver glycogen phosphorylase inhibitors bind at a new allosteric site

Rath, V. L., Ammirati, M. J., Danley, D. E., Ekstrom, J. L., Gibbs, E. M., Hynes, T. R., Mathiowetz, A. M., McPherson, R. K., Olson, T. V., Treadway, J. L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00004-1 · Cited by 129 · see citing works

The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction

Modi, S. P., Sutcliffe, M. J., Primrose, W. U., Lian, L., & Roberts, G. C. K. (1996) · Nature Structural Biology · doi:10.1038/nsb0596-414 · Cited by 128 · see citing works

The 1.8-Å Crystal Structure of a Matrix Metalloproteinase 8-Barbiturate Inhibitor Complex Reveals a Previously Unobserved Mechanism for Collagenase Substrate Recognition

Brandstetter, H., Grams, F., Glitz, D., Lang, A., Huber, R., Bode, W., Krell, H., & Engh, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007475200 · Cited by 127 · see citing works

Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?

Oefner, C., Binggeli, A., Breu, V., Bur, D., Clozel, J.-P., D'Arcy, A., Dorn, A., Fischli, W., Grüninger, F., Güller, R., et al. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)89004-8 · Cited by 126 · see citing works

The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor

Rahuel, J. (1991) · Journal of Structural Biology · doi:10.1016/1047-8477(91)90048-2 · Cited by 122 · see citing works

Binding of the Second Generation Non-nucleoside Inhibitor S-1153 to HIV-1 Reverse Transcriptase Involves Extensive Main Chain Hydrogen Bonding

Ren, J., Nichols, C. E., Bird, L. E., Fujiwara, T., Sugimoto, H., Stuart, D. I., & STAMMERS, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14316 · Cited by 121 · see citing works

Conformational Change of Elongation Factor Tu (EF-Tu) Induced by Antibiotic Binding

Vogeley, L., Palm, G. J., Mesters, J. R., & Hilgenfeld, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100017200 · Cited by 116 · see citing works

Domain Flexibility in Retroviral Proteases: Structural Implications for Drug Resistant Mutations,

Rose, R. B., Craik, C. S., & Stroud, R. M. (1998) · Biochemistry · doi:10.1021/bi9716074 · Cited by 113 · see citing works

Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats

Abraham, D. J., Wireko, F. C., Randad, R. S., et al. (1992) · Biochemistry · doi:10.1021/bi00153a005 · Cited by 109 · see citing works

Conformational switching in an aspartic proteinase

Lee, A. Y., Gulnik, S., & Erickson, J. W. (1998) · Nature Structural Biology · doi:10.1038/2306 · Cited by 109 · see citing works

Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor

Feng, Y., Likos, J. J., Zhu, L., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s0167-4838(02)00307-2 · Cited by 104 · see citing works

Conformational Dynamics along an Enzymatic Reaction Pathway: Thymidylate Synthase, “the Movie”

Stroud, R. M., & Finer-Moore, J. S. (2002) · Biochemistry · doi:10.1021/bi020598i · Cited by 103 · see citing works

A succession of substrate induced conformational changes ensures the amino acid specificity of Thermus thermophilus prolyl-tRNA synthetase: comparison with histidyl-tRNA synthetase

Yaremchuk, A. D., Tukalo, M. A., Grøtli, M., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4712 · Cited by 101 · see citing works

NMR Characterization of the Metallo-β-lactamase from Bacteroides fragilis and Its Interaction with a Tight-Binding Inhibitor: Role of an Active-Site Loop

Scrofani, S. D. B., Chung, J., Huntley, J. J. A., et al. (1999) · Biochemistry · doi:10.1021/bi990986t · Cited by 99 · see citing works

Inhibitor-induced conformational change in cytochrome P-450CAM

Raag, R., Li, H., Jones, B., & Poulos, T. L. (1993) · Biochemistry · doi:10.1021/bi00068a013 · Cited by 95 · see citing works

Making a Network of Hydrophobic Clusters

Baldwin, R. L. (2002) · Science · doi:10.1126/science.1069893 · Cited by 92 · see citing works

Complexity and simplicity of ligand–macromolecule interactions: the energy landscape perspective

Verkhivker, G. M., Bouzida, D., Gehlhaar, D. K., Rejto, P. A., Freer, S. T., & Rose, P. W. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00310-x · Cited by 90 · see citing works

Active Site Plasticity in d -Amino Acid Oxidase: A Crystallographic Analysis,

Todone, F., Vanoni, M. A., Mozzarelli, A., et al. (1997) · Biochemistry · doi:10.1021/bi9630570 · Cited by 88 · see citing works

Structure-Based Development of Anticancer Drugs

Faig, M., Bianchet, M. A., Winski, S. L., et al. (2001) · Structure · doi:10.1016/s0969-2126(01)00636-0 · Cited by 83 · see citing works

Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis, In Vitro Characterization, and X-ray Crystallography

Wright, S. W., Carlo, A. A., Carty, M. D., Danley, D. E., Hageman, D. L., Karam, G. A., Levy, C. B., Mansour, M. N., Mathiowetz, A. M., McClure, L. D., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010496a · Cited by 83 · see citing works

Computer simulations of protein folding by targeted molecular dynamics

Ferrara, P., Apostolakis, J., & Caflisch, A. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(20000515)39:3 · Cited by 78 · see citing works

The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor

Zographos, S. E., Oikonomakos, N. G., Tsitsanou, K. E., Leonidas, D. D., Chrysina, E. D., Skamnaki, V. T., Bischoff, H., Goldmann, S., Watson, K. A., & Johnson, L. N. (1997) · Structure · doi:10.1016/s0969-2126(97)00292-x · Cited by 77 · see citing works

Crystal Structure of Nitric Oxide Synthase Bound to Nitro Indazole Reveals a Novel Inactivation Mechanism

Raman, C. S., Li, H., Pavel Martasek, E., Southan, G. J., Masters, B. S. S., & Poulos, T. L. (2001) · Biochemistry · doi:10.1021/bi010957u · Cited by 76 · see citing works

Positions of His‐64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors

SMITH, G. M., Alexander, R., Christianson, D. W., McKeever, B. M., Ponticello, G. S., Springer, J. P., Randall, W. C., Baldwin, J. J., & Habecker, C. N. (1994) · Protein Science · doi:10.1002/pro.5560030115 · Cited by 67 · see citing works

A Moving Story

Falke, J. J. (2002) · Science · doi:10.1126/science.1069823 · Cited by 66 · see citing works

Design of Highly Potent Noncovalent Thrombin Inhibitors That Utilize a Novel Lipophilic Binding Pocket in the Thrombin Active Site

Tucker, T. J., Lumma, W. C., Mulichak, A. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960762y · Cited by 65 · see citing works

Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors

Suresh, S., Bressi, J. C., Kennedy, K. J., Verlinde, C. L. M. J., Gelb, M. H., & Hol, W. G. J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4588 · Cited by 63 · see citing works

Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere

Tong, L., Pav, S., Mui, S., Lamarre, D., Yoakim, C., Beaulieu, P. L., & Anderson, P. C. (1995) · Structure · doi:10.1016/s0969-2126(01)00133-2 · Cited by 54 · see citing works

Structure-Based Design of Inhibitors Specific for Bacterial Thymidylate Synthase,

Stout, T. J., Tondi, D., Rinaldi, M., et al. (1999) · Biochemistry · doi:10.1021/bi9815896 · Cited by 52 · see citing works

The application of thermodynamic methods in drug design

Velázquez‐Campoy, A., Luque, I., & Freire, E. (2001) · Thermochimica Acta · doi:10.1016/s0040-6031(01)00671-2 · Cited by 52 · see citing works

Molecular Recognition of Cyclic Urea HIV-1 Protease Inhibitors

Ala, P. J., DeLoskey, R. J., Huston, E. E., Jadhav, P. K., Lam, P. Y. S., Eyermann, C. J., Hodge, C. N., Schadt, M. C., Lewandowski, F. A., Weber, P. C., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12325 · Cited by 43 · see citing works

Brzozowski, A M. et al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389, 753-758

Brzozowski, A. M., Öhman, L., Pike, A. C. W., et al. (1997) · Cited by 42 · see citing works

Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancerdrug 1843U89

Weichsel, A., & Montfort, W. R. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1295-1095 · Cited by 36 · see citing works

Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase

Fritz, T. A., Tondi, D., Finer-Moore, J. S., et al. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00067-9 · Cited by 32 · see citing works

Bis Tertiary Amide Inhibitors of the HIV-1 Protease Generated via Protein Structure-Based Iterative Design

Melnick, M., Reich, S., Lewis, K. K., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960092w · Cited by 30 · see citing works

The crystal structure of human α‐thrombin complexed with LY178550, a nonpeptidyl, active site‐directed inhibitor

Chirgadze, N. Y., Sall, D. J., Klimkowski, V. J., et al. (1997) · Protein Science · doi:10.1002/pro.5560060705 · Cited by 27 · see citing works

Crystal structures of cystathionine γ-synthase inhibitor complexes rationalize the increased affinity of a novel inhibitor

Steegborn, C., Laber, B., Messerschmidt, A., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4880 · Cited by 25 · see citing works

The crystal structures of human α‐thrombin complexed with active site‐directed diamino benzo[ b ] thiophene derivatives: A binding mode for a structurally novel class of inhibitors

Chirgadze, N. Y., Sall, D. J., Briggs, S., et al. (2000) · Protein Science · doi:10.1110/ps.9.1.29 · Cited by 25 · see citing works

Energetics of the specific binding interaction of the first three zinc fingers of the transcription factor TFIIIA with its cognate DNA sequence

Liggins, J. R., & Privalov, P. L. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(2000)41:4+ · Cited by 24 · see citing works

The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates

Pouplana, R., Pérez, C., Sánchez, J., et al. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008094616324 · Cited by 18 · see citing works

Building Blocks, Hinge-Bending Motions and Protein Topology

Sinha, N., Tsai, C.-J., & Nussinov, R. (2001) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2001.10506747 · Cited by 13 · see citing works

Oseltamivir Phosphate

Graul, A., Leeson, P. A., & Castañer, J. (1999) · Drugs of the Future · doi:10.1358/dof.1999.024.11.555874 · Cited by 10 · see citing works

Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery

Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771 · see citing works

Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · see citing works

Graph Convolutional Neural Networks for Predicting Drug-Target Interactions

Torng, W., & Altman, R. B. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00628 · Cited by 371 · see citing works

Binding MOAD (Mother Of All Databases)

Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328 · see citing works

Exploring the role of receptor flexibility in structure-based drug discovery

Feixas, F., Lindert, S., Sinko, W., & McCammon, J. A. (2014) · Biophysical Chemistry · doi:10.1016/j.bpc.2013.10.007 · Cited by 156 · see citing works

Molecular Docking Screens Using Comparative Models of Proteins

Fan, H., Irwin, J. J., Webb, B. M., Klebe, G., Shoichet, B. K., & Sali, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9003706 · Cited by 135 · see citing works

Solubility-Weighted Index: fast and accurate prediction of protein solubility

Bhandari, B. K., Gardner, P. P., & Lim, C. S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa578 · Cited by 97 · see citing works

Systematic exploitation of multiple receptor conformations for virtual ligand screening.

Bottegoni, G., Rocchia, W., Rueda, M., Abagyan, R., & Cavalli, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018845 · Cited by 96 · see citing works

Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein

Alexander, C. G., Jürgens, M. C., Shepherd, D. A., Freund, S. M. V., Ashcroft, A. E., & Ferguson, N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308846110 · Cited by 85 · see citing works

Protein flexibility in drug discovery: from theory to computation.

Buonfiglio, R., Recanatini, M., & Masetti, M. (2015) · ChemMedChem · doi:10.1002/cmdc.201500086 · Cited by 73 · see citing works

Protein-Protein Interactions as Drug Targets

Wendt, M. D. (2012) · Topics in Medicinal Chemistry · doi:10.1007/978-3-642-28965-1_1 · Cited by 9 · see citing works

Prediction of Lipophilicity of Orthopramides by Comparative Molecular Field Analysis (CoMFA)

유성은, & 신영아 (1995) · Bulletin of the Korean Chemical Society · Cited by 1 · see citing works

A New Straightforward Method for Lipophilicity (logP) Measurement using 19F NMR Spectroscopy

Wang, Z., Jeffries, B. F., Felstead, H. R., et al. (2019) · Journal of Visualized Experiments · doi:10.3791/58567 · Cited by 6 · see citing works

A New Straightforward Method for Lipophilicity (logP) Measurement using 19F NMR Spectroscopy

Wang, Z., Jeffries, B. F., Felstead, H. R., et al. (2019) · Journal of Visualized Experiments · doi:10.3791/58567-v

Lipophilicity and antiproliferative activity profiling of 2-benzylidencycloalkanones

Hallgas, B., Dobos, Z., Agócs, A., et al. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.05.027 · Cited by 12 · see citing works

The Comparison Between the Calculated and HPLC-Predicted Lipophilicity Parameters for Selected Groups of Drugs

Stasiak, J., Koba, M., Bober, L., et al. (2013) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207311316080003 · Cited by 5 · see citing works